Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valacyclovir for Cognitive Impairment in Bipolar Disorder
NCT00428298Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Mar 2007
- Primary completion
- Aug 2012
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of valaciclovir in bipolar disorder (BD), sponsored by Johns Hopkins University. Started Mar 2007; status: completed.
02
Drugs
valaciclovir
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00428298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00428298.